Rheumatoid Factor (RF) Test

The big picture: Rheumatoid Factor (RF) IgM is an antibody produced by the immune system when it mistakenly attacks the body’s own tissues. While primarily linked to rheumatoid arthritis (RA), it can also be found in other autoimmune conditions and some infections. RF IgM targets the body’s own IgG antibodies, forming immune complexes that accumulate in joints, causing inflammation and tissue damage. Elevated RF IgM levels are a key marker in diagnosing and assessing the severity of rheumatoid arthritis, but it is not exclusive to RA.

Role in autoimmune disease: In RA, RF IgM contributes to joint inflammation by binding to IgG, creating immune complexes that trigger the immune response. While most commonly associated with RA, elevated RF IgM can also occur in other autoimmune diseases like Sjögren’s syndrome and lupus, as well as chronic infections like hepatitis C.

Clinical significance: High RF IgM levels are seen in about 70-80% of RA patients, particularly those with more severe disease and greater joint damage risk. However, RF IgM can also be elevated in other conditions, so it’s usually combined with other tests like anti-CCP antibodies for a more accurate RA diagnosis.

Managing elevated RF IgM: Treatment for RA often involves disease-modifying antirheumatic drugs (DMARDs) like methotrexate or biologics to control inflammation and prevent joint damage. Physical therapy and lifestyle changes also play a role in managing symptoms and slowing disease progression.